16 March 2021 – Stasera Italia, the Italian way to the COVID-19 vaccine

COVID-eVax is the second Italian vaccine to enter clinical trials and the first of its kind to reach that stage in Europe. On Stasera Italia, Luigi Aurisicchio - CEO of Takis - and Lucio Rovati - CEO of Rottapharm - answered key questions about the main features of COVID-eVax, the ongoing clinical trial and the Italian consortium we have put together to produce our vaccine in Italy.